1 Study Coverage
    1.1 Powder Hemostatic Agent Product Introduction
    1.2 Market by Type
        1.2.1 Global Powder Hemostatic Agent Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Absorbable Hemostatic Agent
        1.2.3 Not Absorbable Hemostatic Agent
    1.3 Market by Application
        1.3.1 Global Powder Hemostatic Agent Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Home Care
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Powder Hemostatic Agent Sales Estimates and Forecasts 2017-2028
    2.2 Global Powder Hemostatic Agent Revenue Estimates and Forecasts 2017-2028
    2.3 Global Powder Hemostatic Agent Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Powder Hemostatic Agent Sales by Region
        2.4.1 Global Powder Hemostatic Agent Sales by Region (2017-2022)
        2.4.2 Global Sales Powder Hemostatic Agent by Region (2023-2028)
    2.5 Global Powder Hemostatic Agent Revenue by Region
        2.5.1 Global Powder Hemostatic Agent Revenue by Region (2017-2022)
        2.5.2 Global Powder Hemostatic Agent Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Powder Hemostatic Agent Sales by Manufacturers
        3.1.1 Global Top Powder Hemostatic Agent Manufacturers by Sales (2017-2022)
        3.1.2 Global Powder Hemostatic Agent Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Powder Hemostatic Agent in 2021
    3.2 Global Powder Hemostatic Agent Revenue by Manufacturers
        3.2.1 Global Powder Hemostatic Agent Revenue by Manufacturers (2017-2022)
        3.2.2 Global Powder Hemostatic Agent Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Powder Hemostatic Agent Revenue in 2021
    3.3 Global Powder Hemostatic Agent Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Powder Hemostatic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Powder Hemostatic Agent Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Powder Hemostatic Agent Sales by Type
        4.1.1 Global Powder Hemostatic Agent Historical Sales by Type (2017-2022)
        4.1.2 Global Powder Hemostatic Agent Forecasted Sales by Type (2023-2028)
        4.1.3 Global Powder Hemostatic Agent Sales Market Share by Type (2017-2028)
    4.2 Global Powder Hemostatic Agent Revenue by Type
        4.2.1 Global Powder Hemostatic Agent Historical Revenue by Type (2017-2022)
        4.2.2 Global Powder Hemostatic Agent Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Powder Hemostatic Agent Revenue Market Share by Type (2017-2028)
    4.3 Global Powder Hemostatic Agent Price by Type
        4.3.1 Global Powder Hemostatic Agent Price by Type (2017-2022)
        4.3.2 Global Powder Hemostatic Agent Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Powder Hemostatic Agent Sales by Application
        5.1.1 Global Powder Hemostatic Agent Historical Sales by Application (2017-2022)
        5.1.2 Global Powder Hemostatic Agent Forecasted Sales by Application (2023-2028)
        5.1.3 Global Powder Hemostatic Agent Sales Market Share by Application (2017-2028)
    5.2 Global Powder Hemostatic Agent Revenue by Application
        5.2.1 Global Powder Hemostatic Agent Historical Revenue by Application (2017-2022)
        5.2.2 Global Powder Hemostatic Agent Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Powder Hemostatic Agent Revenue Market Share by Application (2017-2028)
    5.3 Global Powder Hemostatic Agent Price by Application
        5.3.1 Global Powder Hemostatic Agent Price by Application (2017-2022)
        5.3.2 Global Powder Hemostatic Agent Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Powder Hemostatic Agent Market Size by Type
        6.1.1 North America Powder Hemostatic Agent Sales by Type (2017-2028)
        6.1.2 North America Powder Hemostatic Agent Revenue by Type (2017-2028)
    6.2 North America Powder Hemostatic Agent Market Size by Application
        6.2.1 North America Powder Hemostatic Agent Sales by Application (2017-2028)
        6.2.2 North America Powder Hemostatic Agent Revenue by Application (2017-2028)
    6.3 North America Powder Hemostatic Agent Market Size by Country
        6.3.1 North America Powder Hemostatic Agent Sales by Country (2017-2028)
        6.3.2 North America Powder Hemostatic Agent Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Powder Hemostatic Agent Market Size by Type
        7.1.1 Europe Powder Hemostatic Agent Sales by Type (2017-2028)
        7.1.2 Europe Powder Hemostatic Agent Revenue by Type (2017-2028)
    7.2 Europe Powder Hemostatic Agent Market Size by Application
        7.2.1 Europe Powder Hemostatic Agent Sales by Application (2017-2028)
        7.2.2 Europe Powder Hemostatic Agent Revenue by Application (2017-2028)
    7.3 Europe Powder Hemostatic Agent Market Size by Country
        7.3.1 Europe Powder Hemostatic Agent Sales by Country (2017-2028)
        7.3.2 Europe Powder Hemostatic Agent Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Powder Hemostatic Agent Market Size by Type
        8.1.1 Asia Pacific Powder Hemostatic Agent Sales by Type (2017-2028)
        8.1.2 Asia Pacific Powder Hemostatic Agent Revenue by Type (2017-2028)
    8.2 Asia Pacific Powder Hemostatic Agent Market Size by Application
        8.2.1 Asia Pacific Powder Hemostatic Agent Sales by Application (2017-2028)
        8.2.2 Asia Pacific Powder Hemostatic Agent Revenue by Application (2017-2028)
    8.3 Asia Pacific Powder Hemostatic Agent Market Size by Region
        8.3.1 Asia Pacific Powder Hemostatic Agent Sales by Region (2017-2028)
        8.3.2 Asia Pacific Powder Hemostatic Agent Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Powder Hemostatic Agent Market Size by Type
        9.1.1 Latin America Powder Hemostatic Agent Sales by Type (2017-2028)
        9.1.2 Latin America Powder Hemostatic Agent Revenue by Type (2017-2028)
    9.2 Latin America Powder Hemostatic Agent Market Size by Application
        9.2.1 Latin America Powder Hemostatic Agent Sales by Application (2017-2028)
        9.2.2 Latin America Powder Hemostatic Agent Revenue by Application (2017-2028)
    9.3 Latin America Powder Hemostatic Agent Market Size by Country
        9.3.1 Latin America Powder Hemostatic Agent Sales by Country (2017-2028)
        9.3.2 Latin America Powder Hemostatic Agent Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Powder Hemostatic Agent Market Size by Type
        10.1.1 Middle East and Africa Powder Hemostatic Agent Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Powder Hemostatic Agent Revenue by Type (2017-2028)
    10.2 Middle East and Africa Powder Hemostatic Agent Market Size by Application
        10.2.1 Middle East and Africa Powder Hemostatic Agent Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Powder Hemostatic Agent Revenue by Application (2017-2028)
    10.3 Middle East and Africa Powder Hemostatic Agent Market Size by Country
        10.3.1 Middle East and Africa Powder Hemostatic Agent Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Powder Hemostatic Agent Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Johnson & Johnson?Ethicon?
        11.1.1 Johnson & Johnson?Ethicon? Corporation Information
        11.1.2 Johnson & Johnson?Ethicon? Overview
        11.1.3 Johnson & Johnson?Ethicon? Powder Hemostatic Agent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Johnson & Johnson?Ethicon? Powder Hemostatic Agent Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Johnson & Johnson?Ethicon? Recent Developments
    11.2 Celox Medical
        11.2.1 Celox Medical Corporation Information
        11.2.2 Celox Medical Overview
        11.2.3 Celox Medical Powder Hemostatic Agent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Celox Medical Powder Hemostatic Agent Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Celox Medical Recent Developments
    11.3 Amed Therapeutics
        11.3.1 Amed Therapeutics Corporation Information
        11.3.2 Amed Therapeutics Overview
        11.3.3 Amed Therapeutics Powder Hemostatic Agent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Amed Therapeutics Powder Hemostatic Agent Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Amed Therapeutics Recent Developments
    11.4 Cryolife
        11.4.1 Cryolife Corporation Information
        11.4.2 Cryolife Overview
        11.4.3 Cryolife Powder Hemostatic Agent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Cryolife Powder Hemostatic Agent Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Cryolife Recent Developments
    11.5 BioCer Entwicklungs-GmbH
        11.5.1 BioCer Entwicklungs-GmbH Corporation Information
        11.5.2 BioCer Entwicklungs-GmbH Overview
        11.5.3 BioCer Entwicklungs-GmbH Powder Hemostatic Agent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 BioCer Entwicklungs-GmbH Powder Hemostatic Agent Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 BioCer Entwicklungs-GmbH Recent Developments
    11.6 Yunnan Baiyao
        11.6.1 Yunnan Baiyao Corporation Information
        11.6.2 Yunnan Baiyao Overview
        11.6.3 Yunnan Baiyao Powder Hemostatic Agent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Yunnan Baiyao Powder Hemostatic Agent Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Yunnan Baiyao Recent Developments
    11.7 HHAO TECHNOLOGY
        11.7.1 HHAO TECHNOLOGY Corporation Information
        11.7.2 HHAO TECHNOLOGY Overview
        11.7.3 HHAO TECHNOLOGY Powder Hemostatic Agent Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 HHAO TECHNOLOGY Powder Hemostatic Agent Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 HHAO TECHNOLOGY Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Powder Hemostatic Agent Industry Chain Analysis
    12.2 Powder Hemostatic Agent Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Powder Hemostatic Agent Production Mode & Process
    12.4 Powder Hemostatic Agent Sales and Marketing
        12.4.1 Powder Hemostatic Agent Sales Channels
        12.4.2 Powder Hemostatic Agent Distributors
    12.5 Powder Hemostatic Agent Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Powder Hemostatic Agent Industry Trends
    13.2 Powder Hemostatic Agent Market Drivers
    13.3 Powder Hemostatic Agent Market Challenges
    13.4 Powder Hemostatic Agent Market Restraints
14 Key Findings in The Global Powder Hemostatic Agent Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Powder Hemostatic Agent Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Absorbable Hemostatic Agent
    Table 3. Major Manufacturers of Not Absorbable Hemostatic Agent
    Table 4. Global Powder Hemostatic Agent Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Powder Hemostatic Agent Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Powder Hemostatic Agent Sales by Region (2017-2022) & (K Units)
    Table 7. Global Powder Hemostatic Agent Sales Market Share by Region (2017-2022)
    Table 8. Global Powder Hemostatic Agent Sales by Region (2023-2028) & (K Units)
    Table 9. Global Powder Hemostatic Agent Sales Market Share by Region (2023-2028)
    Table 10. Global Powder Hemostatic Agent Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Powder Hemostatic Agent Revenue Market Share by Region (2017-2022)
    Table 12. Global Powder Hemostatic Agent Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Powder Hemostatic Agent Revenue Market Share by Region (2023-2028)
    Table 14. Global Powder Hemostatic Agent Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Powder Hemostatic Agent Sales Share by Manufacturers (2017-2022)
    Table 16. Global Powder Hemostatic Agent Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Powder Hemostatic Agent Revenue Share by Manufacturers (2017-2022)
    Table 18. Powder Hemostatic Agent Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Powder Hemostatic Agent Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Powder Hemostatic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Powder Hemostatic Agent as of 2021)
    Table 21. Powder Hemostatic Agent Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Powder Hemostatic Agent Product Offered
    Table 23. Date of Manufacturers Enter into Powder Hemostatic Agent Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Powder Hemostatic Agent Sales by Type (2017-2022) & (K Units)
    Table 26. Global Powder Hemostatic Agent Sales by Type (2023-2028) & (K Units)
    Table 27. Global Powder Hemostatic Agent Sales Share by Type (2017-2022)
    Table 28. Global Powder Hemostatic Agent Sales Share by Type (2023-2028)
    Table 29. Global Powder Hemostatic Agent Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Powder Hemostatic Agent Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Powder Hemostatic Agent Revenue Share by Type (2017-2022)
    Table 32. Global Powder Hemostatic Agent Revenue Share by Type (2023-2028)
    Table 33. Powder Hemostatic Agent Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Powder Hemostatic Agent Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Powder Hemostatic Agent Sales by Application (2017-2022) & (K Units)
    Table 36. Global Powder Hemostatic Agent Sales by Application (2023-2028) & (K Units)
    Table 37. Global Powder Hemostatic Agent Sales Share by Application (2017-2022)
    Table 38. Global Powder Hemostatic Agent Sales Share by Application (2023-2028)
    Table 39. Global Powder Hemostatic Agent Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Powder Hemostatic Agent Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Powder Hemostatic Agent Revenue Share by Application (2017-2022)
    Table 42. Global Powder Hemostatic Agent Revenue Share by Application (2023-2028)
    Table 43. Powder Hemostatic Agent Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Powder Hemostatic Agent Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Powder Hemostatic Agent Sales by Type (2017-2022) & (K Units)
    Table 46. North America Powder Hemostatic Agent Sales by Type (2023-2028) & (K Units)
    Table 47. North America Powder Hemostatic Agent Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Powder Hemostatic Agent Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Powder Hemostatic Agent Sales by Application (2017-2022) & (K Units)
    Table 50. North America Powder Hemostatic Agent Sales by Application (2023-2028) & (K Units)
    Table 51. North America Powder Hemostatic Agent Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Powder Hemostatic Agent Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Powder Hemostatic Agent Sales by Country (2017-2022) & (K Units)
    Table 54. North America Powder Hemostatic Agent Sales by Country (2023-2028) & (K Units)
    Table 55. North America Powder Hemostatic Agent Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Powder Hemostatic Agent Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Powder Hemostatic Agent Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Powder Hemostatic Agent Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Powder Hemostatic Agent Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Powder Hemostatic Agent Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Powder Hemostatic Agent Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Powder Hemostatic Agent Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Powder Hemostatic Agent Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Powder Hemostatic Agent Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Powder Hemostatic Agent Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Powder Hemostatic Agent Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Powder Hemostatic Agent Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Powder Hemostatic Agent Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Powder Hemostatic Agent Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Powder Hemostatic Agent Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Powder Hemostatic Agent Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Powder Hemostatic Agent Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Powder Hemostatic Agent Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Powder Hemostatic Agent Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Powder Hemostatic Agent Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Powder Hemostatic Agent Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Powder Hemostatic Agent Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Powder Hemostatic Agent Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Powder Hemostatic Agent Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Powder Hemostatic Agent Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Powder Hemostatic Agent Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Powder Hemostatic Agent Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Powder Hemostatic Agent Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Powder Hemostatic Agent Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Powder Hemostatic Agent Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Powder Hemostatic Agent Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Powder Hemostatic Agent Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Powder Hemostatic Agent Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Powder Hemostatic Agent Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Powder Hemostatic Agent Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Powder Hemostatic Agent Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Powder Hemostatic Agent Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Powder Hemostatic Agent Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Powder Hemostatic Agent Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Powder Hemostatic Agent Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Powder Hemostatic Agent Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Powder Hemostatic Agent Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Powder Hemostatic Agent Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Powder Hemostatic Agent Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Powder Hemostatic Agent Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Powder Hemostatic Agent Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Powder Hemostatic Agent Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Powder Hemostatic Agent Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Powder Hemostatic Agent Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Johnson & Johnson?Ethicon? Corporation Information
    Table 106. Johnson & Johnson?Ethicon? Description and Major Businesses
    Table 107. Johnson & Johnson?Ethicon? Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. Johnson & Johnson?Ethicon? Powder Hemostatic Agent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Johnson & Johnson?Ethicon? Recent Developments
    Table 110. Celox Medical Corporation Information
    Table 111. Celox Medical Description and Major Businesses
    Table 112. Celox Medical Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Celox Medical Powder Hemostatic Agent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Celox Medical Recent Developments
    Table 115. Amed Therapeutics Corporation Information
    Table 116. Amed Therapeutics Description and Major Businesses
    Table 117. Amed Therapeutics Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Amed Therapeutics Powder Hemostatic Agent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Amed Therapeutics Recent Developments
    Table 120. Cryolife Corporation Information
    Table 121. Cryolife Description and Major Businesses
    Table 122. Cryolife Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Cryolife Powder Hemostatic Agent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Cryolife Recent Developments
    Table 125. BioCer Entwicklungs-GmbH Corporation Information
    Table 126. BioCer Entwicklungs-GmbH Description and Major Businesses
    Table 127. BioCer Entwicklungs-GmbH Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. BioCer Entwicklungs-GmbH Powder Hemostatic Agent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. BioCer Entwicklungs-GmbH Recent Developments
    Table 130. Yunnan Baiyao Corporation Information
    Table 131. Yunnan Baiyao Description and Major Businesses
    Table 132. Yunnan Baiyao Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. Yunnan Baiyao Powder Hemostatic Agent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Yunnan Baiyao Recent Developments
    Table 135. HHAO TECHNOLOGY Corporation Information
    Table 136. HHAO TECHNOLOGY Description and Major Businesses
    Table 137. HHAO TECHNOLOGY Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. HHAO TECHNOLOGY Powder Hemostatic Agent Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. HHAO TECHNOLOGY Recent Developments
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Powder Hemostatic Agent Distributors List
    Table 143. Powder Hemostatic Agent Customers List
    Table 144. Powder Hemostatic Agent Market Trends
    Table 145. Powder Hemostatic Agent Market Drivers
    Table 146. Powder Hemostatic Agent Market Challenges
    Table 147. Powder Hemostatic Agent Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Powder Hemostatic Agent Product Picture
    Figure 3. Global Powder Hemostatic Agent Market Share by Type in 2021 & 2028
    Figure 3. Absorbable Hemostatic Agent Product Picture
    Figure 4. Not Absorbable Hemostatic Agent Product Picture
    Figure 5. Global Powder Hemostatic Agent Market Share by Application in 2021 & 2028
    Figure 6. Hospitals
    Figure 7. Clinics
    Figure 8. Home Care
    Figure 9. Powder Hemostatic Agent Report Years Considered
    Figure 10. Global Powder Hemostatic Agent Sales 2017-2028 (K Units)
    Figure 11. Global Powder Hemostatic Agent Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Powder Hemostatic Agent Revenue 2017-2028 (US$ Million)
    Figure 13. Global Powder Hemostatic Agent Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Powder Hemostatic Agent Sales Market Share by Region (2017-2022)
    Figure 15. Global Powder Hemostatic Agent Sales Market Share by Region (2023-2028)
    Figure 16. North America Powder Hemostatic Agent Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Powder Hemostatic Agent Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Powder Hemostatic Agent Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Powder Hemostatic Agent Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Powder Hemostatic Agent Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Powder Hemostatic Agent Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Powder Hemostatic Agent Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Powder Hemostatic Agent Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Powder Hemostatic Agent Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Powder Hemostatic Agent Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Powder Hemostatic Agent Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Powder Hemostatic Agent in the World: Market Share by Powder Hemostatic Agent Revenue in 2021
    Figure 28. Global Powder Hemostatic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Powder Hemostatic Agent Sales Market Share by Type (2017-2028)
    Figure 30. Global Powder Hemostatic Agent Revenue Market Share by Type (2017-2028)
    Figure 31. Global Powder Hemostatic Agent Sales Market Share by Application (2017-2028)
    Figure 32. Global Powder Hemostatic Agent Revenue Market Share by Application (2017-2028)
    Figure 33. North America Powder Hemostatic Agent Sales Market Share by Type (2017-2028)
    Figure 34. North America Powder Hemostatic Agent Revenue Market Share by Type (2017-2028)
    Figure 35. North America Powder Hemostatic Agent Sales Market Share by Application (2017-2028)
    Figure 36. North America Powder Hemostatic Agent Revenue Market Share by Application (2017-2028)
    Figure 37. North America Powder Hemostatic Agent Sales Share by Country (2017-2028)
    Figure 38. North America Powder Hemostatic Agent Revenue Share by Country (2017-2028)
    Figure 39. U.S. Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Powder Hemostatic Agent Sales Market Share by Type (2017-2028)
    Figure 42. Europe Powder Hemostatic Agent Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Powder Hemostatic Agent Sales Market Share by Application (2017-2028)
    Figure 44. Europe Powder Hemostatic Agent Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Powder Hemostatic Agent Sales Share by Country (2017-2028)
    Figure 46. Europe Powder Hemostatic Agent Revenue Share by Country (2017-2028)
    Figure 47. Germany Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 48. France Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Powder Hemostatic Agent Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Powder Hemostatic Agent Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Powder Hemostatic Agent Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Powder Hemostatic Agent Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Powder Hemostatic Agent Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Powder Hemostatic Agent Revenue Share by Region (2017-2028)
    Figure 58. China Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 61. India Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Powder Hemostatic Agent Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Powder Hemostatic Agent Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Powder Hemostatic Agent Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Powder Hemostatic Agent Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Powder Hemostatic Agent Sales Share by Country (2017-2028)
    Figure 73. Latin America Powder Hemostatic Agent Revenue Share by Country (2017-2028)
    Figure 74. Mexico Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Powder Hemostatic Agent Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Powder Hemostatic Agent Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Powder Hemostatic Agent Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Powder Hemostatic Agent Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Powder Hemostatic Agent Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Powder Hemostatic Agent Revenue Share by Country (2017-2028)
    Figure 83. Turkey Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 85. U.A.E Powder Hemostatic Agent Revenue (2017-2028) & (US$ Million)
    Figure 86. Powder Hemostatic Agent Value Chain
    Figure 87. Powder Hemostatic Agent Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed